title: Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillation.
authors.affiliation: Dr. Stefano Barco, MD, Department of Internal Medicine, IRCCS Policlinico "San Matteo" Foundation, University of Pavia, Viale Camillo Golgi, 19 - 27100 Pavia, Italy, Tel.: +39 0328 9610085, Fax: +39 0382 502093, E-mail: s.barco@amc.uva.nl.
authors.forename: Stefano
authors.initials: S
authors.lastname: Barco
authors.forename: Michiel
authors.initials: M
authors.lastname: Coppens
authors.forename: Erik-Jan
authors.initials: EJ
authors.lastname: van den Dool
authors.forename: Daan
authors.initials: D
authors.lastname: van de Kerkhof
authors.forename: An K
authors.initials: AK
authors.lastname: Stroobants
authors.forename: Saskia
authors.initials: S
authors.lastname: Middeldorp
mesh_terms: D000284:Administration, Oral; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage*; D000069604:Dabigatran; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D061466:Lopinavir / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage*; D019438:Ritonavir / Q000008:administration & dosage*; D016896:Treatment Outcome; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D001562:Benzimidazoles; D011480:Protease Inhibitors; D011725:Pyridines; D014812:Vitamin K; D061466:Lopinavir; D000069604:Dabigatran; D019438:Ritonavir